Unbiased Health News

Health news covering health policy and insurance, FDA decisions and drug approvals, recalls, public health and disease outbreaks, medical research and the drug industry. Studies are identified by institution and design, and early findings are labeled as early.Read moreShow lessFAQ

Health laws and agency actions are also reported in our US politics news section, and health care costs in our economy news section. Browse all news topics we track.

FSSAI Seizes 3,280 Tonnes of Food Worth Rs 82 Crore and Cancels 52 Licences in Festive-Season Drive

India's food regulator inspected 56,431 establishments between Sept. 1 and Nov. 5, seized 3,279.57 tonnes of food it called banned or non-compliant, and suspended 1,133 licences. Of the 43,939 samples collected, 23,648 had been analysed so far, with 2,273 found non-compliant.

Zylox-Tonbridge and GL Capital Agree to HK$1.48 Billion Stake in LifeTech, Plan Merger Push

Zylox-Tonbridge and GL Capital conditionally agreed on Nov. 6 to buy new LifeTech Scientific shares worth about HK$1.48 billion, which would make their joint vehicle LifeTech's largest shareholder. Zylox says it intends to pursue a full merger, but no merger terms have been announced and the share subscription is still conditional.

Arrowhead Reports One Injection Cut LDL and Triglycerides in 31-Patient Phase 1 Trial

Arrowhead Pharmaceuticals and the Cleveland Clinic presented Nov. 7 at the American Heart Association meeting the first full dataset for ARO-DIMER-PA, a single RNAi molecule that silences both PCSK9 and APOC3. Cholesterol and triglyceride numbers were large, but this is a small, early safety-and-dosing study with no heart-attack or stroke data. The open question is whether lowering both lipids at once translates into fewer cardiovascular events.

Mayo Autopsy Study: Women With Parkinson's Had Twice the Odds of Heavy Alzheimer's Plaque Burden

A Mayo Clinic analysis of 230 autopsied brains found women with Parkinson's carried more Alzheimer's-type amyloid plaque than men, with odds of a high burden above double after adjusting for age and the main Alzheimer's risk gene. Tau pathology and cognitive impairment did not differ by sex. Whether anti-amyloid drugs could help any Parkinson's patients is a question for future study, not a finding.

J&J Says Icotyde Pill Beat Placebo in Psoriatic Arthritis Trial, 58% to 41%

Johnson & Johnson said its once-daily oral pill Icotyde met the primary endpoint in a 552-patient Phase 3 psoriatic arthritis trial, with 58% of patients reaching ACR20 at Week 16 versus 41% on placebo. The drug is approved only for plaque psoriasis so far, and any expansion to psoriatic arthritis still needs FDA review in a crowded field.

Murphy's Stroke at 53 Fits a Pattern: Stroke Rates for Adults 20 to 54 Nearly Doubled Since 1993

Sen. Chris Murphy's Oct. 31 stroke, at 53, is part of a documented rise in strokes among younger adults, with incidence for ages 20 to 54 climbing from 33.90 to 62.18 cases per 100,000. His office has not said what type of stroke it was or what caused it.

Definium Says Single-Dose LSD Tablet Beat Placebo in Late-Stage Anxiety and Depression Trials

Definium Therapeutics reports that DT120, an orally disintegrating LSD tablet, met its primary endpoints in phase III trials for generalized anxiety disorder and major depressive disorder. The placebo-adjusted gains on anxiety were roughly 5 points on the Hamilton scale across two studies. Whether those gains last past 12 weeks, and whether regulators accept the blinding in these trials, is still the open question.

Pelacarsen Cut Lp(a) 78% but Did Not Reduce Heart Attacks or Strokes in 8,322-Patient Phase 3 Trial

Full Lp(a)HORIZON results, presented today, Nov. 7, at the American Heart Association meeting and published in NEJM, show pelacarsen lowered lipoprotein(a) by 78% with no drop in major cardiovascular events: 12.3% on the drug versus 12.1% on placebo. Novartis is dropping the drug for cardiovascular disease and keeping an aortic stenosis study going. Amgen's rival olpasiran, which uses a similar approach, is still in development.

FDA Opens Zolgensma Tumor Investigation, Extends Risk Finding to Itvisma, Says Benefits Still Outweigh Risks

A day after Novartis disclosed nine tumor reports, the FDA said two cases show Zolgensma's viral vector DNA inserted at the GLI1 cancer gene and applied the neoplasia risk to Itvisma, which has no reported tumors. The agency says benefits still outweigh risks while it weighs regulatory action and reviews whether the warning label and follow-up studies are adequate.

Twelve Midwife-Led Birth Centres Have Closed in England Since 2019, Six Under Labour

Twelve midwife-led birth centres have shut in England since 2019, six of them permanently since Labour took office in July 2024. Separately, NHS managers warn that up to 20 of 155 consultant-led maternity units may have to close. The choice between centres run by midwives and units run by doctors is shrinking, and the government's maternity taskforce has yet to say how it will respond.

India's Cancer Drug Margin Cap Takes Effect Monday: 1,031 Formulations Cut, Steepest Drop 96.45%

India's drug price regulator capped trade margins at 30% on 137 cancer drugs, and the revised prices take effect Monday, Nov. 9. The government estimates annual consumer savings of Rs 3,502.31 crore, though that is a projection and only 76 companies have filed new prices so far.

Son Says Father's Assisted Death in Canada Came Within Days, Not Months; Justice Canada Cites Eligibility Safeguards

Eric Edmeades says his father Baz, in his late 70s, died through Canada's MAiD program on Feb. 27, 2024, far sooner than the family was told to expect, and calls the system "way past appropriate." Justice Canada says the law requires a voluntary request, informed consent and other safeguards. Ottawa announced legislation on Oct. 27, 2026 to allow advance requests while blocking MAiD for mental illness alone, so the argument over where the lines sit is still live.

Drug-Resistant Infections Kill an Estimated 35,000 a Year in the EU, and The Lancet Projects 39 Million Deaths Worldwide by 2050

Antimicrobial resistance is estimated to kill about 35,000 people a year in the EU and roughly 35,200 a year in the UK. A Lancet projection puts direct bacterial AMR deaths at 39 million worldwide between 2025 and 2050. Researchers are pushing vaccines, phage therapy and a broader 'One Health' approach, while the UN Environment Programme says a new study suggests warming may be speeding resistance in salmonella.

Dengue Outbreak at Sanya Construction Sites Puts Thousands of Workers in Quarantine, Workers Say

A dengue outbreak at high-end residential construction projects in Sanya, on China's Hainan island, has led to lockdowns and quarantine, state-controlled Beijing News reported Oct. 31. Workers put the number affected at 4,000 to 5,000. Dengue does not spread person to person, so the scale of the quarantine and the true case count are the open questions.

Two women skydivers die after midair collision near Lake Elsinore, California

Two experienced, licensed women skydivers died Friday, Nov. 6, after colliding about 150 feet above the ground near Skydive Elsinore, according to the drop zone. They were training for a women's upright formation record. The Riverside County Sheriff's Office says its investigation is ongoing, and a cause has not been determined.

Stanford Team Reports Human Brain Tissue Filled Cavities in Mouse Brains in Nature Study

Stanford researchers implanted lab-grown human brain organoids into mice bred without most of their cerebral cortex, and the human tissue grew to fill more than 90 percent of the cavities. The team says the model could help study schizophrenia, cerebral palsy and dementia, and stresses these are not mice that think like humans.

Samsung Bioepis Files Keytruda Biosimilar With FDA, Presents 555-Patient Lung Cancer Data

Samsung Bioepis applied to the FDA on Oct. 30 to sell SB27, a copy of Merck's Keytruda, and showed Phase 3 lung cancer data at a Phoenix conference on Nov. 6. Keytruda brought in $31.7 billion in 2025 and makes up about half of Merck's revenue. Two U.S. filings are now in, roughly two years before Merck expects U.S. biosimilar competition.

India Has Run Public Cancer Screening Since 2016, Yet Many Patients Are Still Diagnosed Late

India's government screening program covers oral, breast and cervical cancer for adults 30 and older, but oncologists say many patients still show up with advanced disease. The stakes are large: an estimated 13.92 lakh new cases and about 7.7 lakh deaths in 2020. What's open is how many of those cases could have been caught sooner.

Heart Valve Disease Death Rate Among Americans 65+ Rose Nearly 5% From 2018 to 2023, Preliminary AHA Study Finds

After almost two decades of decline, the heart valve disease death rate for Americans 65 and older climbed from about 104 to 109.2 per 100,000 between 2018 and 2023, according to preliminary research from Allegheny General Hospital. The authors project it will stay near that level through 2040. The study has not been peer-reviewed, and what is driving the reversal is still an open question.

Little Giant recalls 3.66 million ladders after 25 reports of sudden retracting and 19 injuries

The U.S. Consumer Product Safety Commission announced a recall of about 3,662,000 Little Giant ladders because their Rapid Locks can fail to hold. Little Giant has received 25 reports of retracting ladders, including three involving head injuries. Owners are told to stop using affected ladders until they get a repair kit, and the holiday decorating season is about to start.

Health News: Frequently Asked Questions

What health news does Unbiased Headlines cover?

Health policy and insurance, Medicare and Medicaid, FDA decisions, drug approvals and recalls, public health and infectious disease outbreaks, medical research and clinical trials, and the pharmaceutical and health care industries. Stories explain what was decided or found and who it affects.

How are medical studies reported?

Research stories name the study, the journal or institution, and, where available, its size and design. Early-stage results, including animal studies and preprints that have not been peer reviewed, are labeled as such. Findings are attributed to the researchers, and studies are linked where available.

Is the health news on this page medical advice?

No. The page reports health news, research and policy. It is not medical advice and is not a substitute for guidance from a doctor or other qualified health professional. Questions about your own health, medication or treatment should go to your clinician.

How often is the health news page updated?

The page is updated throughout the day as stories are published. Each card carries its posting time and source count, with recent stories near the top. Past health stories are kept in our archive, linked at the bottom of the page, and readers who join free can personalize the feed.

Where can I see the sources behind health stories?

Sources are linked on each health story, alongside any public filing, release or report where available. The Sources page lists the more than 110 outlets Unbiased Headlines draws on, and the Editorial Method page explains how those outlets are chosen and how stories are written.